Concepedia

Dimitri Lodygin

DL

Statistics

Publications

8

Citations

822

H-Index

8

Active since

2002

Affiliations

Max Planck Institute of Biochemistry(Current)

Max Planck Society

Ludwig-Maximilians-Universität München

Dimitri Lodygin is an author at Max Planck Institute of Biochemistry specializing in oncology, epigenetic alterations in cancer, and epigenetics.

Publications per year

2002–2015

8

Publications

8

Functional Epigenomics Identifies Genes Frequently Silenced in Prostate Cancer

Dimitri Lodygin, Alexey Epanchintsev, Antje Menssen et al. · Cancer Research · 2005 · 286 citations · Full text

, , +17

Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression

Dimitri Lodygin, Joachim Diebold, Heiko Hermeking · Oncogene · 2004 · 89 citations

, , +16

Downregulation of 14-3-3σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation

Paulette Mhawech, Ana Benz, Christelle Cerato et al. · Modern Pathology · 2004 · 84 citations

, , +14

Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma

Dimitri Lodygin, Amir S. Yazdi, Christian A. Sander et al. · Oncogene · 2003 · 84 citations

, , +17

Frontrunners of T cell activation: Initial, localized Ca <sup>2+</sup> signals mediated by NAADP and the type 1 ryanodine receptor

Insa M. A. Wolf, Björn‐Philipp Diercks, Ellen Gattkowski et al. · Science Signaling · 2015 · 80 citations

, , +17

1–5 of 8